Searchable News & Info From Reliable Online Sources.
- Federal appellate court okays Planned Parenthood funding halt
A three-judge panel overturned an injunction stopping the Trump administration from halting Medicaid funding for abortion provider Planned Parenthood. ...[TheTopNews] Read More.8 hours ago - Cancer drug combo shows promise for patients resistant to standard treatments
A promising drug combination could help people with leukemia who don't respond to traditional treatments, according to new research.A team at Oregon Health and Science University made the discovery by analyzing samples from more than 300 patients with acute myeloid leukemia, or AML.More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia, data show. It is also one of the most aggressive.WHY ‘STARVING CANCER’ COULD BE KEY TO SLOWING DISEASE GROWTH, ACCORDING TO DOCTORSThe researchers paired venetoclax, a drug commonly used to treat leukemia, with palbociclib, which is used for breast cancer. This resulted in significantly stronger and more durable leukemia-fighting activity than venetoclax alone.The findings were confirmed in human tissue samples, as well as in mouse models carrying human leukemia cells."The data show that this drug regimen may be especially effective in patients whose tumors exhibit features that cause… ...[TheTopNews] Read More.15 hours ago - Controversial CDC panel to review aluminum salts used in many vaccines
A controversial Centers for Disease Control and Prevention panel is gearing up to review the "safety" of a common additive used in many vaccines. ...[TheTopNews] Read More.17 hours ago - Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasonsGLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb.A study published in JAMA in January 2025 — which looked at more than 125,000 overweight or obese people — found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them.Dr. John Batsis, a geriatrician and obesity specialist at the University of North Carolina School of Medicine, told The New York Times in a recent report that people over 65 years old are "prime targets" for this medication, as obesity prevalence is about 40% in older adults.4 ANTI-AGING APPROACHES REVEALED IN 2025 THAT MAY HELP AMERICANS LIVE LONGERThese drugs, which mimic a natural gut hormone called GLP-1 (glucagon-like peptide-1), are primarily used for type 2 diabetes and weight management. However, they have also… ...[TheTopNews] Read More.22 hours ago
- Flu: How are hospitals in your area affected?
Use our interactive tool to explore the latest flu numbers in your area ...[TheTopNews] Read More.23 hours ago - My son was given world’s most expensive gene therapy drug – now he can walkFive-year-old Edward can walk independently, his mum says, and she hopes he will lead a happy life. ...[TheTopNews] Read More.1 day ago
- ‘Having skin cancer while pregnant made me feel so guilty’Emma Giannuzzi used sunbeds throughout her late teens and was twice diagnosed with melanoma. ...[TheTopNews] Read More.1 day ago
- Diabetes patients experience lower death rate with common medicationA large new study suggests that statins may help more people with type 2 diabetes than previously thought.Researchers found that the cholesterol-lowering drugs reduced the risk of death and serious cardiovascular events not only in high-risk patients, but also in those considered low-risk based on standard 10-year heart disease predictions, according to a press release.While statins are commonly prescribed to people with diabetes, there has been uncertainty about whether patients with a low predicted risk of cardiovascular disease would benefit from taking them.SIMPLE LIFESTYLE CHANGES COULD SLASH HEART ATTACK RISK FOR MILLIONS, SCIENTISTS REPORTTo explore this, researchers from the University of Hong Kong analyzed health records from a large U.K. medical database known as IQVIA Medical Research Data.The study included adults aged 25 to 84 with type 2 diabetes who had no serious heart disease or liver problems when the study began. Participants were followed for as long as 10… ...[TheTopNews] Read More.2 days ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
